Prospective study on cardiopulmonary bypass prime reduction and its effect on intraoperative blood product and hemoconcentrator use

Perfusion

Volumn 20, Issue 1, 2005, Pages 31-37

  Sobieski II, Michael A ^a,b   Slaughter, Mark S ^a   Hart, David E ^a   Pappas, Patroklos S ^a   Tatooles, Antone J ^a  

^a ADVOCATE CHRIST MEDICAL CENTER   (United States)

^b Cardiac Surgery Clinical Research Center Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA CLAMPING; ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; BLOOD VOLUME; BODY SURFACE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CRYSTALLOID; DEVICE; EXTRACORPOREAL CIRCULATION; FEASIBILITY STUDY; FEMALE; HEART HEMODYNAMICS; HEART PERFUSION; HEMATOCRIT; HEMOCONCENTRATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; URINE VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; ERYTHROCYTE TRANSFUSION; FEASIBILITY STUDIES; FEMALE; HEMOFILTRATION; HUMANS; INTRAOPERATIVE PERIOD; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 14544305501     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659105pf783oa     Document Type: Article

References (24)

1. Roe BB, Swenson EE, Hepps SA, Bruin DL. Total body perfusion in cardiac operations. Use of perfusate of balanced electrolytes and low molecular weight dextran. Arch Surg 1964; 88: 152-56.
2. Eising GP, Pfauder M, Niemeyer M et al. Retrograde autologous priming: is it useful in elective on-pump coronary artery bypass surgery? Ann Thorac Surg 2003; 75: 23-27.
3. Rosengart TK, DeBois W, O'Hara M et al. Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg 1998; 115: 426-38; discussion 438-9.
4. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.
5. Jansen PG, te Velthuis HT, Bulder ER et al. Reduction in prime volume attenuates the hyperdynamic response after cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 544-50.
6. Utley JR, Wachtel C, Cain RB et al. Effects of hypothermia, hemodilution, and pump oxygenation on organ water content, blood flow, oxygen delivery, and renal function. Ann Thorac Surg 1981; 31: 121-33.
7. Ohri SK, Becket J, Brannan J et al. Effects of cardiopulmonary bypass on gut blood flow, oxygen utilization, and intramucosal pH. Ann Thorac Surg 1994; 57: 1193-99.
8. Engoren MC, Habib RH, Zacharias A et al. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74; 1180-86.
9. Goodnough LT, Johnston MF, Toy PT. The variability of transfusion practice in coronary artery bypass surgery. JAMA 1991; 265: 86-90.
10. Surgenor DM, Wallace EL, Churchill WH et al. Red cell transfusions in coronary artery bypass surgery (DRG 106 and 107). Transfusion 1992; 32: 458-64.
11. Janssens M, Hartstein G, David JL. Reduction in requirements for allogeneic blood products: pharmacologic methods. Ann Thorac Surg 1996; 62: 1944-50.
12. Aldea CS, Doursounian M, O'Gara P et al. Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study. Ann Thorac Surg 1996; 62: 410-18.
13. von Segesser LK, Tozzi P, Malliabrrena I et al. Miniaturization in cardiopulmonary bypass. Perfusion 2003; 18 219-24.
14. Myers GJ, Legare JF, Sullivan JA et al. Use of autologous blood as part of the perfusate for cardiopulmonary bypass: a priming technique. Perfusion 2002; 17: 211-16.
15. Shapira OM, Aldea GS, Treanor PR et al. Reduction of allogenic blood transfusions after open-heart operations by lowering cardiopulmonary prime volume. Ann Thorac Surg 1998; 66: 987-88.
16. Cormack JE, Forrest RJ, Groom RC, Morton J. Size makes a difference: use of a low-prime cardiopulmonary bypass circuit and autologous priming in small adults. Perfusion 2000; 15: 129-35.
17. Cromer MJ, Wolk DR. A minimal prime technique that allows for higher circulating hemoglobin on cardiopulmonary bypass. Perfusion 1998; 13: 311-13.
18. Ferguson TB, Hammill BG, Peterson ED et al. Risk profiles and outcomes for isolated coronary bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg 2002; 73: 480-90.
19. Lip G, Felmeden D. Antiplatelet agents and anticoagulants for hypertension. Cochrane Database Syst Rev 2004; 3: CD003186.
20. Englberger L, Faeh B, Berdat PA et al. Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg 2004; 26: 96-101.
21. Spiess BD, Royston D, Levy JH et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004; 44: 1143-48.
22. Wallis JP, Wells AW, Matthews JN, Chapman CE. Long-term survival after blood transfusion: a population based study in the North of England. Transfusion 2004; 44: 1025-32.
23. Dellinger EP, Anaya DA. Infectious and immunologic consequences of blood transfusion. Crit Care 2004; 8: S18-23.
24. Brest van Kempen AB, Gasiorek JM, Bloemendaal K et al. Low-prime perfusion circuit and autologous priming in CABG surgery on a Jehovah's Witness: a case report. Perfusion 2002; 17: 69-72.